中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2012年
6期
510-512
,共3页
袁义%章海均%庞清江%张波
袁義%章海均%龐清江%張波
원의%장해균%방청강%장파
膝关节%骨关节炎%关节镜%麻醉药,局部%倍他米松
膝關節%骨關節炎%關節鏡%痳醉藥,跼部%倍他米鬆
슬관절%골관절염%관절경%마취약,국부%배타미송
Knee joint%Osteoarthritis%Arthroscopy%Anesthetics,local%Betamethasone
目的 观察膝关节镜清理术后联合罗哌卡因和复方倍他米松关节腔注射治疗膝关节骨性关节炎的疗效.方法 因膝关节骨性关节炎行关节镜清理手术的164例患者随机分为3组:联合治疗组62例,复方倍他米松组54例和对照组48例.采用Lequesne的膝关节骨性关节炎评分标准,分别于术前、术后1周、6周、12周进行疗效评估.结果 164例患者均获有效随访,术前、术后1、6、12周疗效评分联合治疗组分别为(21.3±4.8)分、(12.3±4.3)分、(9.2±6.3)分、(8.2±5.5)分；复方倍他米松组分别为(21.7±5.1)分、(14.7±5.8)分、(12.4±5.8)分、(9.1±4.8)分；对照组分别为(20.9±4.2)分、(15.2±5.5)分、(15.8±6.3)分、(14.4±6.9)分.联合治疗组、复方倍他米松组及对照组各组内治疗前后疗效比较,差异有统计学意义(均P＜0.05),组间比较表明术后1周、6周、12周,联合治疗组及复方倍他米松组疗效较对照组有统计学意义(P＜0.05),术后1周、6周,联合治疗组疗效对比复方倍他米松组差异有统计学意义(P＜0.05),而术后12周差异无统计学意义(P＞0.05).结论 膝骨性关节炎在关节镜清理术后,关节腔内注射罗哌卡因及复方倍他米松,可有效缓解术后疼痛,促进功能恢复.
目的 觀察膝關節鏡清理術後聯閤囉哌卡因和複方倍他米鬆關節腔註射治療膝關節骨性關節炎的療效.方法 因膝關節骨性關節炎行關節鏡清理手術的164例患者隨機分為3組:聯閤治療組62例,複方倍他米鬆組54例和對照組48例.採用Lequesne的膝關節骨性關節炎評分標準,分彆于術前、術後1週、6週、12週進行療效評估.結果 164例患者均穫有效隨訪,術前、術後1、6、12週療效評分聯閤治療組分彆為(21.3±4.8)分、(12.3±4.3)分、(9.2±6.3)分、(8.2±5.5)分；複方倍他米鬆組分彆為(21.7±5.1)分、(14.7±5.8)分、(12.4±5.8)分、(9.1±4.8)分；對照組分彆為(20.9±4.2)分、(15.2±5.5)分、(15.8±6.3)分、(14.4±6.9)分.聯閤治療組、複方倍他米鬆組及對照組各組內治療前後療效比較,差異有統計學意義(均P＜0.05),組間比較錶明術後1週、6週、12週,聯閤治療組及複方倍他米鬆組療效較對照組有統計學意義(P＜0.05),術後1週、6週,聯閤治療組療效對比複方倍他米鬆組差異有統計學意義(P＜0.05),而術後12週差異無統計學意義(P＞0.05).結論 膝骨性關節炎在關節鏡清理術後,關節腔內註射囉哌卡因及複方倍他米鬆,可有效緩解術後疼痛,促進功能恢複.
목적 관찰슬관절경청리술후연합라고잡인화복방배타미송관절강주사치료슬관절골성관절염적료효.방법 인슬관절골성관절염행관절경청리수술적164례환자수궤분위3조:연합치료조62례,복방배타미송조54례화대조조48례.채용Lequesne적슬관절골성관절염평분표준,분별우술전、술후1주、6주、12주진행료효평고.결과 164례환자균획유효수방,술전、술후1、6、12주료효평분연합치료조분별위(21.3±4.8)분、(12.3±4.3)분、(9.2±6.3)분、(8.2±5.5)분；복방배타미송조분별위(21.7±5.1)분、(14.7±5.8)분、(12.4±5.8)분、(9.1±4.8)분；대조조분별위(20.9±4.2)분、(15.2±5.5)분、(15.8±6.3)분、(14.4±6.9)분.연합치료조、복방배타미송조급대조조각조내치료전후료효비교,차이유통계학의의(균P＜0.05),조간비교표명술후1주、6주、12주,연합치료조급복방배타미송조료효교대조조유통계학의의(P＜0.05),술후1주、6주,연합치료조료효대비복방배타미송조차이유통계학의의(P＜0.05),이술후12주차이무통계학의의(P＞0.05).결론 슬골성관절염재관절경청리술후,관절강내주사라고잡인급복방배타미송,가유효완해술후동통,촉진공능회복.
Objective To investigate the effects of intra-articular injection of ropivacaine plus compound betamethasone after arthroscopic debridement for knee osteoarthritis.Methods A total of 164 patients with knee osteoarthritis after arthroscopic debridement were randomly divided into three groups:combination group (n=62) treated by 2 ml sodium hyaluronate and 0.75％ ropivacaine of 5 ml plus 1 ml compound betamethasone,compound betamethasone group (n=54) by 2 ml sodium hyaluronate and 1 ml compound betamethasone,control group (n=48) by simply sodium hyaluronate.The Lequesne Index was used to evaluate the clinical effects before and 1 week,6 weeks and 12 weeks after operation.All patients received at least 12 weeks follow-up Results According to Lequesne Index score criteria,a significant decrease was found in all groups before versus after operation(P＜0.05).The clinical effects in combination group and compound betamethasone group were more improved as compared with control group at 1,6 and 12 weeks after operation (P＜0.05).The effect in combination group was better than compound betamethasone group at 1 and 6 weeks after operation,but not at 12 weeks (P＞0.05).Conclusions The intra-articular injection of ropivacaine plus compound betamethasone after arthroscopic debridement is a good method for relieving pain and improving the knee function.
